Parkinson's freezing of gait device: WALK trial results

How does vibration therapy for Parkinson's work?

The WALK device is a bilateral thigh-worn tool designed to help people with Parkinson's disease manage freezing of gait (FOG). Researchers from the University of Leeds found that this device can be integrated into a supervised home rehabilitation program [1]. It works by delivering local muscle-tendon vibration while the user walks. This is intended to address freezing episodes that often persist even when patients receive dopaminergic treatment [1].

What did the University of Leeds Parkinson's study find?

The University of Leeds ran a single-centre pilot randomised clinical trial [1].

Both groups followed a six-week supervised home programme consisting of 16 sessions [1]. The researchers measured freezing severity in the medication OFF state at the start, after session 8, and after session 16 [1].

Benefits of a thigh-worn gait device for FOG

Out of the 47 randomised participants, 40 completed the follow-up and were included in the main analysis [1]. This represents a retention rate of 85.1% [1]. All of those who completed the study finished the full 16-session programme [1].

Safety appeared stable during the pilot. According to the University of Leeds, no serious device-related adverse events occurred among the completers [1]. One person in the active group did discontinue the trial [1].

Managing Parkinson's freezing of gait at home

You should know that this study is a preprint, meaning it has not yet been peer-reviewed [1]. It was also a pilot trial with a small sample size of 40 completers, which limits how the results can be applied to the wider population [1].

Because this is a pilot study, it does not prove causation. It explores differences in freezing severity and the feasibility of home use, but larger trials are needed to confirm clinical effectiveness [1].

What does this mean for patients?

For people living with Parkinson's, this suggests that wearable vibration technology could eventually become a part of home-based therapy [1]. It provides a potential option for managing the feeling of being "stuck" during movement [1].

But it isn't a ready-to-use consumer product yet. The trial focused on a supervised environment, so you can't replicate these results without professional guidance [1].

What happens next?

The researchers will likely move toward larger, peer-reviewed studies to validate the vibration therapy effects [1]. Future work will need to determine if the active device provides a statistically significant advantage over the sham treatment for long-term mobility [1]. Check the medRxiv listing for updates on the peer-review status of this paper [1].